RCEL News and Press, Avita Medical Inc. From 12/19/23

2023-12-19 20:38:32 ET Summary AVITA Medical's Spray-On Skin Cells device rapidly processes a patient's own skin to treat large dermatological injuries. The company's sales growth is expected to accelerate in 2024 due to the supplement of its RECELL System for full-thickness skin ...

VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today ann...

2023-11-21 09:59:42 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...

2023-11-20 16:52:50 ET Shares of Avita Medical ( NASDAQ: RCEL ) on Monday slumped as much as 11.4% in extended trading, after the skin restoration-focused pharmaceutical company cut its full year 2023 commercial revenue guidance. RCEL stock had cut back the losses and was la...

VALENCIA, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, today ann...

2023-11-10 10:00:34 ET DENVER, Colo., Nov. 10, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Motus GI Holdings Inc (NASDAQ: MOTS), Blink Charging Co (NASDAQ: BLNK), Navitas Semiconductor Corp (NASDA...

2023-11-10 10:00:06 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom September Labor Report Preview: Full Employ...

2023-11-09 20:39:04 ET AVITA Medical, Inc. (RCEL) Q3 2023 Results Conference Call November 09, 2023 04:30 PM ET Company Participants Jessica Ekeberg - Director of Investor Relations Jim Corbett - Chief Executive Officer David O’Toole - Chief Financial Offi...

2023-11-09 16:06:26 ET AVITA Medical press release ( NASDAQ: RCEL ): Q3 GAAP EPS of -$0.34 beats by $0.10 . Revenue of $13.5M (+48.5% Y/Y) beats by $0.21M . Commercial revenue for the fourth quarter 2023 is expected to be in the range of $15.3 to $16.3 million....

VALENCIA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “ Company ”), a regenerative medicine company leading the development and commercialization of first-in-class devices and autologous cellular therapies for skin restoration, tod...